In today’s CEO Daily: Diane Brady talks to Pfizer CEO Albert Bourla about defending science amid a backdrop of political ...

The first-quarter earnings season is heating up—both in tempo and the numbers themselves. More than a third of S&P 500 ...

Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the ...

When the rollback was announced shortly after Trump took action against DEI programs in the federal government by executive ...

Summit Therapeutics' shares dropped 36% after ivonescimab data showed no significant survival benefit. Click to read if SMMT ...

Goldman Sachs on the dollar, and Nomura on the political effect of cheap Chinese imports. Plus: All the news and watercooler chat from Fortune. Good morning. Pfizer’s Albert Bourla has become a ...

Intangible assets are nonphysical resources that generate economic and strategic value, such as patents, trademarks, customer ...

A new film features leading business figures discussing how New York's Commercial Division boosts economic growth and ...

With 1,320 rental apartments and a host of amenities, 25 Water Street is the country’s largest office-to-residential ...

Pfizer ( ($PFE) ) has been popular among investors this week. Here is a recap of the key news on this stock. Pfizer (PFE) has been the focus of ...

So far, SpringWorks – which was spun out of Pfizer in 2017 and has recently received FDA approval for a second therapy for a ...